MARKET INTELLIGENCE . CONSULTINGwww.techsciresearch.com

INDIA DIABETES CARE MARKETFORECAST & OPPORTUNITIES

FY2016 –FY2026

2

Scope of ReportProduct of Interest (POI): Diabetes Care

Review Period

FY2016 – FY2019

Base Year

FY2020

Estimated Year

FY2021

Forecast Period

FY2022 – FY2026

Year Range

Diabetes is the condition in which the body does not properly process food for use as energy. Most of the food we eat is turned into glucose, or sugar, for our bodies to use for energy. The pancreas, an organ that lies near the stomach, makes a hormone called insulin to help glucose get into the cells of our bodies.

Market Segmentation

REGION

• North• South• East• West

END USER

• Home Care Settings• Hospitals• Clinics

PRODUCT TYPE

• Diabetes Drugs • Diabetes Care Devices

• Type 1 Diabetes• Type 2 Diabetes• Gestational Diabetes

TYPE OF DIABETES

3

Table of ContentsS. No. Contents Page No.

1. Product of Interest Introduction: Diabetes Care Market

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Diabetes Care Market

5. Voice of Customers/Customer Insights

6. India Diabetes Care Market Outlook, FY2016-FY2026F

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type (Diabetes Drugs vs. Diabetes Care Devices)

6.2.2. By Type of Diabetes (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)

6.2.3. By End User (Home Care Settings, Hospitals, Clinics)

6.2.4. By Region (North, South, East, West)

6.2.5. By Company

6.3. Product Market Map

4

Table of ContentsS. No. Contents Page No.

7. India Diabetes Care Devices Market Outlook, FY2016-FY2026F

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices)

7.2.2. By Type of Diabetes

7.2.3. By End User

8. India Diabetes Drugs Market Outlook, FY2016-FY2026F

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1.By Product Type (Insulin, Dipeptidyl peptidase-4 (DPP-4) inhibitors, Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists), Others (Sodium-glucose co-transporter-2 (SGLT2) inhibitors, Biguanides, Sulfonylureas))

8.2.2. By Type of Diabetes

8.2.3. By End User

5

Table of ContentsS. No. Contents Page No.

9. Market Dynamics

9.1. Drivers/Opportunities

9.2. Challenges/Restraints

10. Market Trends & Developments

11. Policy Regulatory and Landscape

12. India Economic Profile

13. Competitive Landscape

13.1. Competition Outlook

13.2. Company Profiles (Leading Companies)

13.2.1. Company Details

13.2.2. Products & Services

13.2.3. Financials (As Reported)

13.2.4. Key Market Focus & Geographical Presence

13.2.5. Recent Developments

13.2.6. Key Management Personnel14. Strategic Recommendations

15 About Us & Disclaimer

RESEARCH METHODOLOGY

7

Research Methodology

Identifying Key Opinion Leaders

Questionnaire Design In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to determine top players in the India diabetes care market, overall market size and segmental market size.

In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.

List of industry players and industry specialists was developed.

TechSci conducted interviews with industry experts and industry players for data collection and verification.

Data obtained as a result of primary and secondary research was validated through rigorous triangulation.

The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the India diabetes care market.

Data Collection

Data Filter& Analysis

Research &Intelligence

ActionableInsights Business

Solution

Primary Research Desk Research Company Analysis

Recent Developments Market Changing

Aspects/Dynamics Government Policies Conclusion

Market Participants Key Strengths

LinkedIn TechSci

Internal Database

Factiva Hoovers

Paid Sources

Company Websites

Company Annual Reports

White Paper Study

Financial Reports

Investor Presentations

Regulatory Body Associations,

etc.

Secondary Research

Primary Research

8

Research Methodology

Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of India diabetes care market. The team has

analyzed the outlook of various segments of this market, while considering the major influencing factors such as growing concerns

regarding diabetes among Indian citizens. The study includes market forecasting, which would enable our clients to take better

decisions while planning their strategy to achieve sustainability in India diabetes care market.

Methodology Followed for Calculation of Market Size:

• Market Size By Value : Market size, in terms of value, for the year FY2020 was calculated based on information collected through

exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as manufacturers,

suppliers, channel partners, end users, industry experts, and other industry participants.

• The team interviewed more than 40 – 50 manufacturers, suppliers, 180 – 200 end users, and 15 – 20 industry experts and other

value chain stakeholders in the India diabetes care market to obtain the overall market size from FY2016 to FY2020, which was

validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the

market size data during FY2016-FY2020.

• Respondents were asked about the current and future market growth rates, market shares by product type, by type of diabetes, by

end user, by region and by company. Removing the outlier responses, the geometric mean of growth estimates and supplier wise

revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares

generated across various segments were further triangulated from other stakeholders.

9

Research Methodology

Methodology Followed for Calculation of Market Shares:

Market shares by product type, by type of diabetes, by end user, by region and by company were calculated based on the responses

received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue

generated from various segments of diabetes care market. The final shares were calculated by taking the geometric mean of the

responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey

results in SPSS/Tableau Software.

• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast

India diabetes care market, TechSci Research used various forecast techniques such as:

Moving Average

Time Series Analysis

Regression Analysis

Econometric and Judgmental Analysis

10

Research Methodology

TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci

Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate

market numbers. It should be noted that the figures compiled are only for the organized market including market share data.

Partial List of Companies Interviewed Key Secondary Sources

Novo Nordisk India Private Limited

Sanofi India Limited

Eli Lilly India Pvt. Ltd.

Roche Diagnostics India Pvt Ltd.

Abbott India Limited

Becton Dickinson Private Limited

Johnson & Johnson Private Limited

India Medtronic Pvt. Ltd.

Ypsomed India Private Ltd.

Novartis India Ltd.

World Bank

TechSci Research Proprietary Database & Knowledge

Repository

Company Annual Reports

Industry Magazines

Industry Reports

Statista

News Dailies

Credible Paid Databases

11© TechSci Research

Industry Brief

According to recently released TechSci Research report “India Diabetes Care Market By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, 2026.’’, India diabetes care market is forecast to grow at CAGR of 7.94% in value terms to reach USD2,408.39 million by FY2026. Increasing demand for diabetes care has been generated from the country’s rising diabetic population. Various diabetes care manufacturing giants have introduced continuous glucose monitoring devices specially for type 1 diabetes, hyperglycaemia, and gestational diabetes.

With the growth of urbanization, adoption of an unhealthy lifestyle and spending capacity of consumers in India has led to an increase in the diabetic population, which is driving the diabetes care market across the country.

India diabetes care market is categorized into diabetes drug and diabetes devices. The drug diabetes care segment holds the major market share, followed by devices. The devices category is growing fast in value terms due to feasibility of use. the value share of device diabetes care is anticipated to reach 47.18% by FY2026, owing to the continuous launch of better and easy to handle devices and rising disposable incomes.

Novo Nordisk India Private Limited, Sanofi India Limited, Eli Lilly India Pvt. Ltd., Roche Diagnostics India Pvt Ltd., Abbott India Limited, Becton Dickinson Private Limited, Johnson & Johnson Private Limited, India Medtronic Pvt. Ltd., Ypsomed India Private Ltd. and Novartis India Ltd are some of the companies operating in the India diabetes care market.

“Diabetes care market in India includes several players, including a blend of large multi-nationals as well as small players forming a large unorganized market. Multinational companies such as Abbott India Limited, Sanofi India Limited, Eli Lilly India Pvt, Novo Nordisk India Private Limited, etc., have either set up their production facilities in India or implement contract manufacturing processes, to grab the opportunity of booming diabetes care market and increase of their product portfolio as per consumers drug requirements which is expected to drive the growth of organized sector in the coming years. Also, guidelines related to manufacturing and marketing of diabetes care as per Indian and International standards have been implemented which is primarily focused on the development of newer products, exploitation of technology and enhancement of distribution network. This is expected to give a boost in the country’s Diabetes Care market in the coming years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

12© TechSci Research

Sample Data - Snaphsot

FY2016 FY2020 FY2021E FY2026F

5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 India Diabetes Care Market Size, By Value (USD Million), FY2016–FY2026F

CAGR By ValueXX%

CAGR By ValueYY%

FY2016FY2017FY2018FY2019FY2020

FY2021EFY2022FFY2023FFY2024FFY2025FFY2026F

50%50%50%50%50%50%50%50%50%50%50%

50%50%50%50%50%50%50%50%50%50%50%

Diabetes Drugs Diabetes Care Devices

India Diabetes Care Market Share, By Product Type, By Value, FY2016–FY2026F

India Diabetes Care Devices Market Share, By Type of Diabetes, By Value, FY2016–FY2026F

FY2016FY2017FY2018FY2019FY2020

FY2021EFY2022FFY2023FFY2024FFY2025FFY2026F

33%33%33%33%33%33%33%33%33%33%33%

33%33%33%33%33%33%33%33%33%33%33%

34%34%34%34%34%34%34%34%34%34%34%

Type 1 Diabetes Type 2 Diabetes Gestational Diabetes

13© TechSci Research

Report Ordering

Report Name: INDIA DIABETES CARE MARKETFORECAST & OPPORTUNITIES

FY2016 –FY2026

To View Sample OR Purchase Report

 

License Type Price Single User License $3500Multi-User License $4500

Custom Research License $7500

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.

Related Reports

• United States Hospital Market By Ownership (Public v/s Private) By Type (General, Specialty, Multi- Specialty) By Type of Services (In-Patient Services v/s Out-Patient Services) By Bed Capacity (Up to 100 beds, 100-500 beds, Above 500 beds) By Region, Competition Forecast & Opportunities, 2026

• India Insulin Delivery Devices Market By Product Type (Pens, Pumps, Pen Needles, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others) By End User (Hospitals & Clinics, Homecare, Others) By Region, Competition Forecast & Opportunities, FY2027

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America708 Third Avenue, Manhattan,

New York, United StatesTel: +1- 646- 360- 1656

Email: sales@techsciresearch.com www.techsciresearch.com

Disclaimer

TechSci Research – Europe54, Old brook, Bretton,

Peterborough, United Kingdom

Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National

Capital Region, U.P. - IndiaTel: +91-120-4523900

Email: sales@techsciresearch.com www.techsciresearch.com